title: Prevalence and timing of postpartum glucose testing and sustained glucose dysregulation after gestational diabetes mellitus.
abstract: OBJECTIVE To estimate the prevalence of postpartum glucose testing within 6 months of pregnancies complicated by gestational diabetes mellitus (GDM), assess factors associated with testing and timing of testing after delivery, and report the test results among tested women. RESEARCH DESIGN AND METHODS This was a retrospective study of 11,825 women who were identified as having GDM using the 100-g oral glucose tolerance test (OGTT) from 1999 to 2006. Postpartum testing (75-g 2-h OGTT or fasting plasma glucose [FPG]) within 6 months of delivery and test results from laboratory databases are reported. Postpartum test results are categorized as normal, impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT), and provisionally diabetic. RESULTS About half (n = 5,939) the women were tested with either a FPG or 75-g OGTT from 7 days to 6 months postpartum. Of these women, 46% were tested during the 6- to 12-week postpartum period. Odds of testing were independently associated with age, race/ethnicity, household income, education, foreign-born status, parity, mode of delivery, having a postpartum visit, having GDM coded at discharge, and pharmacotherapy for GDM. Of the 5,857 women with test results, 16.3% (n = 956) had IFG/IGT and 1.1% (n = 66) had provisional diabetes. After adjustment for demographic and clinical factors, abnormal postpartum test results was associated with having required insulin, glyburide, or metformin during pregnancy and with longer period from delivery to postpartum testing. CONCLUSIONS After a pregnancy complicated by GDM, automated orders for postpartum testing with notification to physicians and electronically generated telephone and e-mail reminder messages to patients may improve the rates of postpartum testing for persistence of glucose intolerance.
authors.affiliation: Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA. jean.m.lawrence@kp.org
authors.forename: Jean M
authors.initials: JM
authors.lastname: Lawrence
authors.forename: Mary Helen
authors.initials: MH
authors.lastname: Black
authors.forename: Jin-Wen
authors.initials: JW
authors.lastname: Hsu
authors.forename: Wansu
authors.initials: W
authors.lastname: Chen
authors.forename: David A
authors.initials: DA
authors.lastname: Sacks
mesh_terms: D000293:Adolescent; D000328:Adult; D001786:Blood Glucose / Q000032:analysis*; D016640:Diabetes, Gestational / Q000097:blood / Q000534:rehabilitation*; D005260:Female; D018149:Glucose Intolerance / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology*; D005951:Glucose Tolerance Test / Q000706:statistics & numerical data; D006801:Humans; D049590:Postpartum Period / Q000097:blood*; D011247:Pregnancy; D015995:Prevalence; D012189:Retrospective Studies; D013997:Time Factors; D055815:Young Adult
chemical_list: D001786:Blood Glucose